Abiraterone in the treatment of metastatic castration-resistant prostate cancer
Elahe A Mostaghel Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Abstract: Androgen deprivation therapy remains the single most effective treatment for the initial therapy of advanced prostate cancer, but is uniformly marked by progression to castration-resi...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2014-01-01
|
| Edice: | Cancer Management and Research |
| On-line přístup: | http://www.dovepress.com/abiraterone-in-the-treatment-of-metastatic-castration-resistant-prosta-a15635 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|